Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Siemens -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wolf who wrote (353)	5/21/2007 9:32:11 AM
From: elmatador	Respond to of 356

A Battered Siemens Names a New Chief Peter Löscher, an executive of the American drug maker Merck, as its chief executive, to succeed Klaus Kleinfeld, who resigned after less than three years because of a bribery investigation on his watch. By BLOOMBERG NEWS Published: May 21, 2007 MUNICH, May 20 (Bloomberg News) — Siemens, Europe’s largest engineering company, named Peter Löscher, an executive of the American drug maker Merck, as its chief executive, to succeed Klaus Kleinfeld, who resigned after less than three years because of a bribery investigation on his watch. Mr. Löscher, president of Merck’s global human health unit, will start his new job July 1, Siemens said in a statement. He will be the first chief executive in Siemens’s 160-year history not to have previously worked at the company. Mr. Kleinfeld said on April 25 that he would quit when his contract ran out at the end of September, after the supervisory board balked at renewing his term. On Sunday, it was announced that he would step down on June 30. Mr. Löscher, 49, an Austrian, will have to restore a corporate reputation battered by an inquiry of fictitious consultant contracts begun on Nov. 15 after the German police searched company buildings and the homes of employees at 30 locations. The investigation spread to countries including Italy and Luxembourg, grabbed the attention of the Securities and Exchange Commission in the United States and led to the departures of Mr. Kleinfeld and the company’s chairman, Heinrich von Pierer. Mr. Löscher is a former head of General Electric’s health care biosciences division, and in April 2006 was named president of Merck’s global human health unit, where he has overseen 35,000 employees and been responsible for Merck’s worldwide marketing and sales..

To: Bill Wolf who wrote (353)	1/23/2009 7:32:18 AM
From: elmatador	Respond to of 356

Germany says cannot confirm Siemens sale plan Fri Jan 23, 2009 7:05am EST Email \| Print \| Share\| Reprints \| Single Page[-] Text [+] Market News Oil pares losses on evidence of OPEC supply cuts Stock futures point to lower Wall Street open GE falters after quarterly results More Business & Investing News... Featured Broker sponsored link BERLIN, Jan 23 (Reuters) - Germany said on Friday it could not confirm that industrial group Siemens AG (SIEGn.DE) planned to sell its 34 percent stake in the nuclear power plant unit of France's Areva (CEPFi.PA), as reported in a French newspaper. "I cannot confirm anything. This is a matter for the companies to decide and we cannot comment here," government spokesman Ulrich Wilhelm said when asked about the report. (Writing by Noah Barkin)